← Leaderboards
Michael Daniel Green
Veterans Health Administration
$877,372
Attributed
$1,077,930
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $594.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,077,930 · 2
VA$0 · 1
By mechanism
R01$676,813 · 1
R21$401,117 · 1
I01$0 · 1
Top collaborators
- Shyam Nyati1 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,640,671
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,755,085
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,983,611
Research focus
ImmunotherapyImmuneRadiation TherapyTumorMacrophageImmune Checkpoint BlockadeCombined Modality TherapyImmune ResponseCellsCombinatorialCell CountResponseMetastatic MelanomaT-LymphocyteMelanomaNeoplastic CellNovel Therapeutic InterventionMolecularModalityNatural ImmunityPublishingCell PhysiologyMediatingAntigen-Presenting Cells
Grant awards (7)
Enhancing Ferroptosis to Augment Responses to Immune Checkpoint Blockade$0
I01 · FY2025 · VA · contact PI
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma$82,478
R01 · FY2024 · CA · contact PI
Enhancing Ferroptosis to Augment Responses to Immune Checkpoint Blockade$0
I01 · FY2024 · VA · contact PI
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma$594,335
R01 · FY2023 · CA · contact PI
Enhancing Ferroptosis to Augment Responses to Immune Checkpoint Blockade$0
I01 · FY2023 · VA · contact PI
Enhancing Ferroptosis to Augment Responses to Immune Checkpoint Blockade$0
I01 · FY2022 · VA · contact PI
Targeting BUB 1 for radio- and immuno-sensitization of Triple Negative Breast Cancer (TNBC)$401,117
R21 · FY2021 · CA · contact PI